EUVIMEDEUVIMED entdecken
Übersichtsarbeit

RNA base editors: The emerging approach of RNA therapeutics

Jinghui Song, Nan Luo, Liting Dong, Jinying Peng, Chengqi Yi iD

WIREs RNA · 2024

DOI: 10.1002/wrna.1844 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift WIREs RNA, 2024. Verfasst von Jinghui Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China. Hauptthemen laut MEDLINE: RNA, CRISPR-Cas Systems. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 112 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China, Beijing Municipal Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA‐based therapeutics offer a flexible and reversible approach for treating genetic disorders, such as antisense oligonucleotides, RNA interference, aptamers, mRNA vaccines, and RNA editing. In recent years, significant advancements have been made in RNA base editing to correct disease‐relevant point mutations. These achievements have significantly influenced the fields of biotechnology, biomedical research and therapeutics development. In this article, we provide a comprehensive overview of the design and performance of contemporary RNA base editors, including A‐to‐I, C‐to‐U, A‐to‐m 6 A, and U‐to‐Ψ. We compare recent innovative developments and highlight their applications in disease‐relevant contexts. Lastly, we discuss the limitations and future prospects of utilizing RNA base editing for therapeutic purposes. This article is categorized under: RNA Processing > RNA Editing and Modification RNA in Disease and Development > RNA in Development

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNACRISPR-Cas SystemsGene EditingOligonucleotides, AntisenseRNA Interference

Stichwörter der Autor:innen

A‐to‐IC‐to‐UN6‐methyladenosineRNA editingRNA modificationRNA therapeuticsbase editorpseudouridinesingle nucleotide mutations

Substanzen

RNAOligonucleotides, Antisense

Autor:innen und Institutionen

  • State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China.
  • Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China.
  • Department of Chemical Biology and Synthetic and Functional Biomolecules Center, College of Chemistry and Molecular Engineering, Peking University, Beijing, China.
  • Beijing Advanced Center of RNA Biology (BEACON), Peking University, Beijing, China.

ORCID-Profile: Chengqi Yi

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • National Natural Science Foundation of China
  • Beijing Municipal Science and Technology Commission
  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park

Zitieren

APA

Song, J., Luo, N., Dong, L., Peng, J., & Yi, C. (2024). RNA base editors: The emerging approach of RNA therapeutics. WIREs RNA. https://doi.org/10.1002/wrna.1844

Vancouver

Song J, Luo N, Dong L, Peng J, Yi C. RNA base editors: The emerging approach of RNA therapeutics. WIREs RNA. 2024. doi:10.1002/wrna.1844

BibTeX
@article{Song2024,
  author = {Song, Jinghui and Luo, Nan and Dong, Liting and Peng, Jinying and Yi, Chengqi},
  title = {RNA base editors: The emerging approach of RNA therapeutics},
  journal = {WIREs RNA},
  year = {2024},
  doi = {10.1002/wrna.1844}
}
Kostenlos starten →